Henricus P. M. Kunst
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Henricus P. M. Kunst has a total of 131 co-authors. Here are the top co-authors by number of shared publications:
- Yasin Temel
Department of Neurosurgery, Maastricht University, Maastricht, The Netherlands
9 shared publications - Max E. Keizer
Department of Neurosurgery, Maastricht University Medical Center, 6202 AZ Maastricht, The Netherlands
5 shared publications - Koos Hovinga
Department of Neurosurgery, Maastricht University Medical Center, 6202 AZ Maastricht, The Netherlands
4 shared publications - Pawan Kishore Ravindran
Department of Neurosurgery, Maastricht University Medical Center, 6202 AZ Maastricht, The Netherlands
4 shared publications - Thijs T. G. Jansen
Department of Otolaryngology and Head and Neck Surgery, Radboud University Medical Center, Nijmegen, the Netherlands
4 shared publications - Andy J. Beynon
Department of Otorhinolaryngology, Radboud university medical center, Nijmegen, The Netherlands
3 shared publications
Latest Publications
- Open Access
- 24 June 2026
- Published by Springer Nature in Neuroradiology
- Vol. 68 (7) , 1-13
Consensus on the use of artificial intelligence in the management and measurement of vestibular schwannomas: A protocol for a modified delphi consensus
Introduction: The assessment of vestibular schwannomas (VS) requires a standardized approach as growth is a key element in defining treatment strategy. Volumetric measurements offer higher sensitivity and precision, but existing methods of image segmentation, are labour-intensive and prone to variability. Artificial intelligence (AI) frameworks to segment VS using magnetic resonance imaging (MRI) achieving state-of-the-art capability can fully automate the detection and segmentation of VS. These tools can be used for automating the extraction process of various linear and volumetric measurements. A consistent approach to recording data, facilitated by AI, will allow the accumulation and comparison of evidence to identify the most effective treatments for patients with VS. Aims: This protocol aims to develop a Delphi consensus for the assessment of VS and deployment of AI-based image analysis as a tool for use in VS management. Methods: A three-phase consensus study will be undertaken; Phase 1: systematic review (PROSPERO registration number CRD42024604452) of trials and observational studies reporting the measurement of VS to identify a list of candidate indicators; Phase 2: refinement of this list and development of a set of questionnaire questions performed by our local steering committee; and Phase 3: a two-round Delphi questionnaire and consensus meeting with expert stakeholders from the British Skull Base Society (BSBS), European Skull Base Society (ESBS) and European Society of Head and Neck Radiology (ESHNR). Ethics and dissemination: Participants will be recruited through professional bodies. The core reporting set will be disseminated through peer-reviewed publication, co-production with journal editors, research funders and professional bodies, and presentation at national conferences. Clinical trial number: Not applicable.
- 24 June 2026
- Published by Springer Nature in Neuroradiology
- Vol. 68 (7) , 1-13
Open AccessConsensus on the use of artificial intelligence in the management and measurement of vestibular schwannomas: A protocol for a modified delphi consensus
Introduction: The assessment of vestibular schwannomas (VS) requires a standardized approach as growth is a key element in defining treatment strategy. Volumetric measurements offer higher sensitivity and precision, but existing methods of image segmentation, are labour-intensive and prone to variability. Artificial intelligence (AI) frameworks to segment VS using magnetic resonance imaging (MRI) achieving state-of-the-art capability can fully automate the detection and segmentation of VS. These tools can be used for automating the extraction process of various linear and volumetric measurements. A consistent approach to recording data, facilitated by AI, will allow the accumulation and comparison of evidence to identify the most effective treatments for patients with VS. Aims: This protocol aims to develop a Delphi consensus for the assessment of VS and deployment of AI-based image analysis as a tool for use in VS management. Methods: A three-phase consensus study will be undertaken; Phase 1: systematic review (PROSPERO registration number CRD42024604452) of trials and observational studies reporting the measurement of VS to identify a list of candidate indicators; Phase 2: refinement of this list and development of a set of questionnaire questions performed by our local steering committee; and Phase 3: a two-round Delphi questionnaire and consensus meeting with expert stakeholders from the British Skull Base Society (BSBS), European Skull Base Society (ESBS) and European Society of Head and Neck Radiology (ESHNR). Ethics and dissemination: Participants will be recruited through professional bodies. The core reporting set will be disseminated through peer-reviewed publication, co-production with journal editors, research funders and professional bodies, and presentation at national conferences. Clinical trial number: Not applicable.
- Open Access
- 13 March 2026
- Published by Springer Nature in Quality of Life Research
- Vol. 35 (4)
Mapping the neglected topic in head and neck paraganglioma research: a PRISMA scoping review on quality of life
Purpose: Paragangliomas in the head and neck (HNPGL) are rare slow growing neuro-endocrine tumors. The impact of various treatment strategies and tumor characteristics on health-related quality of life (HRQoL) remains unclear. This scoping review aims to map the available evidence and summarize the findings on how HNPGL affects patients’ HRQoL. Methods: A comprehensive literature search was conducted in PubMed, Embase, and Cochrane. Articles were included when presenting a quantification of HRQoL or Patient Reported Outcome Measures in patients with HNPGL ( n ≥ 5). Studies focusing exclusively on paragangliomas outside the head and neck region were excluded. A scoping review using descriptive and inductive thematic analysis was performed and presented using the Prisma-ScR guidelines. Results: Fourteen studies were included presenting quantifiable HRQoL data in patients with HNPGL. The most used HRQoL measure were the Short Form-36 ( n = 4, 29%) and EORTC Core Quality of Life questionnaire (QLQ-C30) ( n = 3, 21%), followed by Short Form-12 ( n = 2, 14%). HNPGL negatively affects HRQoL across several domains, even in patients not requiring an intervention. Specific subgroups, including those with carotid body tumors, multiple tumors, or dysphonia, reported disproportionately lower HRQoL. Conclusion: Current sparse evidence on HRQoL in patients with HNPGL demonstrates significant impairment and identified various factors influencing this outcome. However, further research is necessary to specifically assess the effect of different therapeutic managements on HRQoL.
- 13 March 2026
- Published by Springer Nature in Quality of Life Research
- Vol. 35 (4)
Open AccessMapping the neglected topic in head and neck paraganglioma research: a PRISMA scoping review on quality of life
Purpose: Paragangliomas in the head and neck (HNPGL) are rare slow growing neuro-endocrine tumors. The impact of various treatment strategies and tumor characteristics on health-related quality of life (HRQoL) remains unclear. This scoping review aims to map the available evidence and summarize the findings on how HNPGL affects patients’ HRQoL. Methods: A comprehensive literature search was conducted in PubMed, Embase, and Cochrane. Articles were included when presenting a quantification of HRQoL or Patient Reported Outcome Measures in patients with HNPGL ( n ≥ 5). Studies focusing exclusively on paragangliomas outside the head and neck region were excluded. A scoping review using descriptive and inductive thematic analysis was performed and presented using the Prisma-ScR guidelines. Results: Fourteen studies were included presenting quantifiable HRQoL data in patients with HNPGL. The most used HRQoL measure were the Short Form-36 ( n = 4, 29%) and EORTC Core Quality of Life questionnaire (QLQ-C30) ( n = 3, 21%), followed by Short Form-12 ( n = 2, 14%). HNPGL negatively affects HRQoL across several domains, even in patients not requiring an intervention. Specific subgroups, including those with carotid body tumors, multiple tumors, or dysphonia, reported disproportionately lower HRQoL. Conclusion: Current sparse evidence on HRQoL in patients with HNPGL demonstrates significant impairment and identified various factors influencing this outcome. However, further research is necessary to specifically assess the effect of different therapeutic managements on HRQoL.
- Open Access
- 12 February 2026
- Published by MDPI AG in Preprints.org
Reduction of the Vestibulo-Ocular Reflex on the Non-Tumor Side in Patients with Unilateral Vestibular Schwannoma Due to Bilateral Neural Interaction?
Background: A group of patients with untreated unilateral vestibular schwannoma (UVS) was observed in previous clinical trials, and the results indicated a reduction in the vestibulo-ocular reflex (VOR) on the side of lesion. However, in a subset of patients, a loss of VOR gain was also observed on the contralateral (non-tumor) side, which may indicate the presence of contralateral neural crosstalk. Methods: To understand our previous clinical findings, the present study has expanded its population to investigate whether these unexpected findings are recognized in a significantly larger population of patients with UVS (n=640). Retrospectively, mean VOR gains of all semicircular canals (SCC) were obtained using video head impulse tests (vHIT) and compared between ipsi- and contralateral side of lesion. To eliminate any potential bias resulting from procedural effects, vHIT data was also obtained from a control group of 72 healthy subjects. Results: As expected, a VOR gain reduction was identified on the side of lesion in a substantial proportion of patients with UVS, varying ranging from 19.4% (anterior SCC) to 39.7% (posterior SCC). More interesting was the observation of a significant proportion of patients (21.9%) exhibiting a significant VOR reduction in posterior semicircular canal on the contralateral side, with a strong correlation with the ipsilateral side (r = 0.70). In relation to this phenomenon, our data further demonstrates that possible crosstalk of the superior branch of the vestibular nerve is of less influence on the contralateral side VOR gains compared to that of the inferior branch. Conclusion: Firstly, a reduced VOR gain in the contralateral posterior semicircular canals was found. Secondly, correlations between the inferior vestibular branches in UVS patients were comparable to the control group. These results may support the interactions such as bilateral commissural connectivity between vestibular nuclei.
- 12 February 2026
- Published by MDPI AG in Preprints.org
Open AccessReduction of the Vestibulo-Ocular Reflex on the Non-Tumor Side in Patients with Unilateral Vestibular Schwannoma Due to Bilateral Neural Interaction?
Background: A group of patients with untreated unilateral vestibular schwannoma (UVS) was observed in previous clinical trials, and the results indicated a reduction in the vestibulo-ocular reflex (VOR) on the side of lesion. However, in a subset of patients, a loss of VOR gain was also observed on the contralateral (non-tumor) side, which may indicate the presence of contralateral neural crosstalk. Methods: To understand our previous clinical findings, the present study has expanded its population to investigate whether these unexpected findings are recognized in a significantly larger population of patients with UVS (n=640). Retrospectively, mean VOR gains of all semicircular canals (SCC) were obtained using video head impulse tests (vHIT) and compared between ipsi- and contralateral side of lesion. To eliminate any potential bias resulting from procedural effects, vHIT data was also obtained from a control group of 72 healthy subjects. Results: As expected, a VOR gain reduction was identified on the side of lesion in a substantial proportion of patients with UVS, varying ranging from 19.4% (anterior SCC) to 39.7% (posterior SCC). More interesting was the observation of a significant proportion of patients (21.9%) exhibiting a significant VOR reduction in posterior semicircular canal on the contralateral side, with a strong correlation with the ipsilateral side (r = 0.70). In relation to this phenomenon, our data further demonstrates that possible crosstalk of the superior branch of the vestibular nerve is of less influence on the contralateral side VOR gains compared to that of the inferior branch. Conclusion: Firstly, a reduced VOR gain in the contralateral posterior semicircular canals was found. Secondly, correlations between the inferior vestibular branches in UVS patients were comparable to the control group. These results may support the interactions such as bilateral commissural connectivity between vestibular nuclei.
- Open Access
MRI-Based Prediction of Vestibular Schwannoma: Systematic Review
Background: The vestibular schwannoma (VS) is the most common cerebellopontine angle tumor in adults, exhibiting a highly variable natural history, from stability to rapid growth. Accurate, the non-invasive prediction of tumor behavior is essential to guide personalized management and avoid overtreatment or delayed intervention. Objective: To systematically review and synthesize the evidence on MRI-based biomarkers for predicting VS growth and treatment responses. Methods: We conducted a PRISMA-compliant search of PubMed, EMBASE, and Cochrane databases for studies published between 1 January 2000 and 1 January 2025, addressing MRI predictors of VS growth. Cohort studies evaluating texture features, signal intensity ratios, perfusion parameters, and apparent diffusion coefficient (ADC) metrics were included. Study quality was assessed using the NOS (Newcastle–Ottawa Scale) score, GRADE (Grading of Recommendations, Assessment, Development and Evaluation), and ROBIS (Risk of Bias in Systematic reviews) tool. Data on diagnostic performance, including the area under the receiver operating characteristic (ROC) curve (AUC), sensitivity, specificity, and p value, were extracted and descriptively analyzed. Results: Ten cohort studies (five retrospective, five prospective, total n = 525 patients) met the inclusion criteria. Texture analysis metrics, such as kurtosis and gray-level co-occurrence matrix (GLCM) features, yielded AUCs of 0.65–0.99 for predicting volumetric or linear growth thresholds. Signal intensity ratios on gadolinium-enhanced T1-weighted images for tumor/temporalis muscle achieved a 100% sensitivity and 93.75% specificity. Perfusion MRI parameters (Ktrans, ve, ASL, and DSC derived blood-flow metrics) differentiated growing from stable tumors with AUCs up to 0.85. ADC changes post-gamma knife surgery predicted a favorable response, though the baseline ADC had limited value for natural growth prediction. The heterogeneity in growth definitions, MRI protocols, and retrospective designs remains a key limitation. Conclusions: MRI-based biomarkers may provide exploratory signals associated with VS growth and treatment responses. However, substantial heterogeneity in growth definitions and MRI protocols, small single-center cohorts, and the absence of external validation currently limit clinical implementation.
Open AccessMRI-Based Prediction of Vestibular Schwannoma: Systematic Review
Background: The vestibular schwannoma (VS) is the most common cerebellopontine angle tumor in adults, exhibiting a highly variable natural history, from stability to rapid growth. Accurate, the non-invasive prediction of tumor behavior is essential to guide personalized management and avoid overtreatment or delayed intervention. Objective: To systematically review and synthesize the evidence on MRI-based biomarkers for predicting VS growth and treatment responses. Methods: We conducted a PRISMA-compliant search of PubMed, EMBASE, and Cochrane databases for studies published between 1 January 2000 and 1 January 2025, addressing MRI predictors of VS growth. Cohort studies evaluating texture features, signal intensity ratios, perfusion parameters, and apparent diffusion coefficient (ADC) metrics were included. Study quality was assessed using the NOS (Newcastle–Ottawa Scale) score, GRADE (Grading of Recommendations, Assessment, Development and Evaluation), and ROBIS (Risk of Bias in Systematic reviews) tool. Data on diagnostic performance, including the area under the receiver operating characteristic (ROC) curve (AUC), sensitivity, specificity, and p value, were extracted and descriptively analyzed. Results: Ten cohort studies (five retrospective, five prospective, total n = 525 patients) met the inclusion criteria. Texture analysis metrics, such as kurtosis and gray-level co-occurrence matrix (GLCM) features, yielded AUCs of 0.65–0.99 for predicting volumetric or linear growth thresholds. Signal intensity ratios on gadolinium-enhanced T1-weighted images for tumor/temporalis muscle achieved a 100% sensitivity and 93.75% specificity. Perfusion MRI parameters (Ktrans, ve, ASL, and DSC derived blood-flow metrics) differentiated growing from stable tumors with AUCs up to 0.85. ADC changes post-gamma knife surgery predicted a favorable response, though the baseline ADC had limited value for natural growth prediction. The heterogeneity in growth definitions, MRI protocols, and retrospective designs remains a key limitation. Conclusions: MRI-based biomarkers may provide exploratory signals associated with VS growth and treatment responses. However, substantial heterogeneity in growth definitions and MRI protocols, small single-center cohorts, and the absence of external validation currently limit clinical implementation.
- Open Access
Predictors of Growth of Vestibular Schwannoma After Gamma Knife Treatment: A Systematic Review
Background: GKRS shows a high success rate in controlling growth of vestibular schwannoma, but a small number of tumors still grow after treatment. However, only a few studies have investigated the predictive factors of this growth. Objective: Here, we aim to explore the growth determinants of vestibular schwannoma after GKRS. Methods: This paper has analyzed literature published between 2000 and 2024 from PubMed, EMBASE, and Cochrane databases. Potential determinants, including age, gender, tumor volume, radiation dose, tumor location, and imaging characteristics, have been reviewed. Conclusions: We have found that initial tumor volume, pretreatment growth rate, and imaging ADC value potentially predict growth after GKRS. These findings provide a reference for further optimizing personalized treatment in vestibular schwannoma care.
Open AccessPredictors of Growth of Vestibular Schwannoma After Gamma Knife Treatment: A Systematic Review
Background: GKRS shows a high success rate in controlling growth of vestibular schwannoma, but a small number of tumors still grow after treatment. However, only a few studies have investigated the predictive factors of this growth. Objective: Here, we aim to explore the growth determinants of vestibular schwannoma after GKRS. Methods: This paper has analyzed literature published between 2000 and 2024 from PubMed, EMBASE, and Cochrane databases. Potential determinants, including age, gender, tumor volume, radiation dose, tumor location, and imaging characteristics, have been reviewed. Conclusions: We have found that initial tumor volume, pretreatment growth rate, and imaging ADC value potentially predict growth after GKRS. These findings provide a reference for further optimizing personalized treatment in vestibular schwannoma care.
- Open Access
- 12 June 2025
- Published by Wolters Kluwer Health in Otology & Neurotology
- Vol. 46 (7) , e278-e284
Precision in Practice: Inter- and Intra-rater Reliability of Linear Measurements and Tumor Growth in Vestibular Schwannoma
Objective: The aim of this study is to compare and assess the inter- and intra-rater reliability of various linear measurement techniques for vestibular schwannomas (VS) and their impact on determining tumor growth in a multidisciplinary multicenter setting. Methods: Six experts (neurosurgeons, otorhinolaryngologists, and radiologists) involved in VS management, from two tertiary referral centers, measured linear extrameatal VS tumor size parallel and perpendicular to the petrous ridge, and as maximum axial and maximum coronal diameter. Inter- and intra-rater reliability were evaluated using the intraclass correlation coefficient (ICC). The repeatability coefficient was computed for each measurement direction. Fleiss' kappa was used to determine the degree of agreement on tumor growth. Results: Reliability between raters was significantly excellent (ICC >0.9) across all measurement directions, with the highest ICC observed for measurements parallel to the petrous ridge (ICC, 0.974; 95% CI, 0.957–0.986). Good or excellent reliability was achieved in 95.8% of all intra-rater measurements, with predominantly higher ICC scores for measurements in the coronal plane. Fleiss' kappa for interrater variability of determining tumor growth was highest and substantial for measurements parallel to the petrous ridge 0.672 (95% CI, 0.546–0.799). Conclusion: Linear measurements of VS parallel to the petrous ridge yield excellent interrater reliability and the most favorable repeatability coefficient. Good to excellent intra-rater reliability across all measurement directions was observed. The most accurately defined tumor growth was obtained comparing measurements parallel to the petrous ridge. We recommend measurements parallel to the petrous ridge as the standard linear method for evaluating VS and growth.
- 12 June 2025
- Published by Wolters Kluwer Health in Otology & Neurotology
- Vol. 46 (7) , e278-e284
Open AccessPrecision in Practice: Inter- and Intra-rater Reliability of Linear Measurements and Tumor Growth in Vestibular Schwannoma
Objective: The aim of this study is to compare and assess the inter- and intra-rater reliability of various linear measurement techniques for vestibular schwannomas (VS) and their impact on determining tumor growth in a multidisciplinary multicenter setting. Methods: Six experts (neurosurgeons, otorhinolaryngologists, and radiologists) involved in VS management, from two tertiary referral centers, measured linear extrameatal VS tumor size parallel and perpendicular to the petrous ridge, and as maximum axial and maximum coronal diameter. Inter- and intra-rater reliability were evaluated using the intraclass correlation coefficient (ICC). The repeatability coefficient was computed for each measurement direction. Fleiss' kappa was used to determine the degree of agreement on tumor growth. Results: Reliability between raters was significantly excellent (ICC >0.9) across all measurement directions, with the highest ICC observed for measurements parallel to the petrous ridge (ICC, 0.974; 95% CI, 0.957–0.986). Good or excellent reliability was achieved in 95.8% of all intra-rater measurements, with predominantly higher ICC scores for measurements in the coronal plane. Fleiss' kappa for interrater variability of determining tumor growth was highest and substantial for measurements parallel to the petrous ridge 0.672 (95% CI, 0.546–0.799). Conclusion: Linear measurements of VS parallel to the petrous ridge yield excellent interrater reliability and the most favorable repeatability coefficient. Good to excellent intra-rater reliability across all measurement directions was observed. The most accurately defined tumor growth was obtained comparing measurements parallel to the petrous ridge. We recommend measurements parallel to the petrous ridge as the standard linear method for evaluating VS and growth.
- Open Access
- 4 April 2025
- Published by Springer Nature in Neuroradiology
- Vol. 67 (4) , 1049-1059
Towards clinical implementation of automated segmentation of vestibular schwannomas: a reliability study comparing AI and human performance
Purpose: To evaluate the clinimetric reliability of automated vestibular schwannoma (VS) segmentations by a comparison with human inter-observer variability on T1-weighted contrast-enhanced MRI scans. Methods: This retrospective study employed MR images, including follow-up, from 1,015 patients (median age: 59, 511 men), resulting in 1,856 unique scans. Two nnU-Net models were trained using fivefold cross-validation to create a single-center segmentation model, along with a multi-center model using additional publicly available data. Geometric-based segmentation metrics (e.g. the Dice score) were used to evaluate model performance. To quantitatively assess the clinimetric reliability of the models, automated tumor volumes from a separate test set were compared to human inter-observer variability using the limits of agreement with the mean (LOAM) procedure. Additionally, new agreement limits that include automated annotations are calculated. Results: Both models performed comparable to current state-of-the-art VS segmentation models, with median Dice scores of 91.6% and 91.9% for the single and multi-center models, respectively. There is a stark difference in clinimetric performance between both models: automated tumor volumes of the multi-center model fell within human agreement limits in 73% of the cases, compared to 44% for the single-center model. Newly calculated agreement limits including the single-center model, resulted in very high and wide limits. For the multi-center model, the new agreement limits were comparable to human inter-observer variability. Conclusion: Models with excellent geometric-based metrics do not necessarily imply high clinimetric reliability, demonstrating the need to clinimetrically evaluate models as part of the clinical implementation process. The multi-center model displayed high reliability, warranting its possible future use in clinical practice. However, caution should be exercised when employing the model for small tumors, as the reliability was found to be volume-dependent.
- 4 April 2025
- Published by Springer Nature in Neuroradiology
- Vol. 67 (4) , 1049-1059
Open AccessTowards clinical implementation of automated segmentation of vestibular schwannomas: a reliability study comparing AI and human performance
Purpose: To evaluate the clinimetric reliability of automated vestibular schwannoma (VS) segmentations by a comparison with human inter-observer variability on T1-weighted contrast-enhanced MRI scans. Methods: This retrospective study employed MR images, including follow-up, from 1,015 patients (median age: 59, 511 men), resulting in 1,856 unique scans. Two nnU-Net models were trained using fivefold cross-validation to create a single-center segmentation model, along with a multi-center model using additional publicly available data. Geometric-based segmentation metrics (e.g. the Dice score) were used to evaluate model performance. To quantitatively assess the clinimetric reliability of the models, automated tumor volumes from a separate test set were compared to human inter-observer variability using the limits of agreement with the mean (LOAM) procedure. Additionally, new agreement limits that include automated annotations are calculated. Results: Both models performed comparable to current state-of-the-art VS segmentation models, with median Dice scores of 91.6% and 91.9% for the single and multi-center models, respectively. There is a stark difference in clinimetric performance between both models: automated tumor volumes of the multi-center model fell within human agreement limits in 73% of the cases, compared to 44% for the single-center model. Newly calculated agreement limits including the single-center model, resulted in very high and wide limits. For the multi-center model, the new agreement limits were comparable to human inter-observer variability. Conclusion: Models with excellent geometric-based metrics do not necessarily imply high clinimetric reliability, demonstrating the need to clinimetrically evaluate models as part of the clinical implementation process. The multi-center model displayed high reliability, warranting its possible future use in clinical practice. However, caution should be exercised when employing the model for small tumors, as the reliability was found to be volume-dependent.
- Open Access
Untreated Vestibular Schwannoma: Analysis of the Determinants of Growth
The growth rate of sporadic VS varies considerably, posing challenges for consistent clinical management. This systematic review examines data on factors associated with VS growth, following a protocol registered in the PROSPERO database. The analysis reveals that key predictors of tumor growth include tumor location, initial size, and specific clinical symptoms such as hearing loss and imbalance. Additionally, several studies suggest that growth observed within the first year may serve as an indicator of subsequent progression, enabling the earlier identification of high-risk cases. Emerging factors such as the posture swing test and MRI signal intensity have also been identified as novel predictors that could further refine growth assessments. Our meta-analysis confirms that tumor location, initial size, cystic components, and vestibular symptoms are closely linked to the likelihood of VS growth. This review provides valuable guidance for clinicians in identifying patients who may require closer monitoring or early intervention. By integrating these predictive factors into clinical practice, this review supports more personalized treatment and contributes to the development of more accurate prognostic models for managing untreated sporadic VS.
Open AccessUntreated Vestibular Schwannoma: Analysis of the Determinants of Growth
The growth rate of sporadic VS varies considerably, posing challenges for consistent clinical management. This systematic review examines data on factors associated with VS growth, following a protocol registered in the PROSPERO database. The analysis reveals that key predictors of tumor growth include tumor location, initial size, and specific clinical symptoms such as hearing loss and imbalance. Additionally, several studies suggest that growth observed within the first year may serve as an indicator of subsequent progression, enabling the earlier identification of high-risk cases. Emerging factors such as the posture swing test and MRI signal intensity have also been identified as novel predictors that could further refine growth assessments. Our meta-analysis confirms that tumor location, initial size, cystic components, and vestibular symptoms are closely linked to the likelihood of VS growth. This review provides valuable guidance for clinicians in identifying patients who may require closer monitoring or early intervention. By integrating these predictive factors into clinical practice, this review supports more personalized treatment and contributes to the development of more accurate prognostic models for managing untreated sporadic VS.
- Open Access
Skull-Base Chondrosarcoma: A Systematic Review of the Role of Postoperative Radiotherapy
Surgery and radiotherapy are key elements to the treatment of skull-base chondrosarcomas; however, there is currently no consensus regarding whether or not adjuvant radiotherapy has to be administered. This study searched the EMBASE, Cochrane, and PubMed databases for clinical studies evaluating the long-term prognosis of surgery with or without adjuvant radiotherapy. After reviewing the search results, a total of 22 articles were selected for this review. A total of 1388 patients were included in this cohort, of which 186 received surgery only. With mean follow-up periods ranging from 39.1 to 86 months, surgical treatment provided progression-free survival (PFS) rates ranging from 83.7 to 92.9% at 3 years, 60.0 to 92.9% at 5 years, and 58.2 to 64.0% at 10 years. Postoperative radiotherapy provides PFS rates ranging between 87 and 96.2% at 3 years, 57.1 and 100% at 5 years, and 67 and 100% at 10 years. Recurrence rates varied from 5.3% to 39.0% in the surgery-only approach and between 1.5% and 42.90% for the postoperative radiotherapy group. When considering prognostic variables, higher age, brainstem/optic apparatus compression, and larger tumor volume prior to radiotherapy were found to be significant factors for local recurrence.
Open AccessSkull-Base Chondrosarcoma: A Systematic Review of the Role of Postoperative Radiotherapy
Surgery and radiotherapy are key elements to the treatment of skull-base chondrosarcomas; however, there is currently no consensus regarding whether or not adjuvant radiotherapy has to be administered. This study searched the EMBASE, Cochrane, and PubMed databases for clinical studies evaluating the long-term prognosis of surgery with or without adjuvant radiotherapy. After reviewing the search results, a total of 22 articles were selected for this review. A total of 1388 patients were included in this cohort, of which 186 received surgery only. With mean follow-up periods ranging from 39.1 to 86 months, surgical treatment provided progression-free survival (PFS) rates ranging from 83.7 to 92.9% at 3 years, 60.0 to 92.9% at 5 years, and 58.2 to 64.0% at 10 years. Postoperative radiotherapy provides PFS rates ranging between 87 and 96.2% at 3 years, 57.1 and 100% at 5 years, and 67 and 100% at 10 years. Recurrence rates varied from 5.3% to 39.0% in the surgery-only approach and between 1.5% and 42.90% for the postoperative radiotherapy group. When considering prognostic variables, higher age, brainstem/optic apparatus compression, and larger tumor volume prior to radiotherapy were found to be significant factors for local recurrence.
- Open Access
- 31 July 2023
- Published by Cambridge University Press (CUP) in International Journal of Technology Assessment in Health Care
- Vol. 39 (1) , e46
A first exploration of the economic consequences of an autonomous surgical robot for lateral skull base surgery: an early health technology assessment
Objectives: Lateral skull base procedures, such as translabyrinthine approach (TLA), are challenging. An autonomous surgical robot might be a solution to these challenges. Our aim is to explore in an early phase the economic consequences of an autonomous surgical robot compared with conventional TLA. Methods: An early decision analytic model was constructed in order to perform a step-wise threshold analyses and a sensitivity analysis to analyze the impact of the several factors on the incremental costs. Results: Using surgical robot results in incremental costs – EUR 5,562 per procedure – compared to conventional TLA. These costs are most reduced by higher number of procedures, followed by lower price of the robot, saved operation time, and reduced risk of complication, respectively. Conclusions: The incremental costs of using an autonomous surgical robot can be decreased by choosing applications with a high turnover rate, a long operation time, and a high complication rate.
- 31 July 2023
- Published by Cambridge University Press (CUP) in International Journal of Technology Assessment in Health Care
- Vol. 39 (1) , e46
Open AccessA first exploration of the economic consequences of an autonomous surgical robot for lateral skull base surgery: an early health technology assessment
Objectives: Lateral skull base procedures, such as translabyrinthine approach (TLA), are challenging. An autonomous surgical robot might be a solution to these challenges. Our aim is to explore in an early phase the economic consequences of an autonomous surgical robot compared with conventional TLA. Methods: An early decision analytic model was constructed in order to perform a step-wise threshold analyses and a sensitivity analysis to analyze the impact of the several factors on the incremental costs. Results: Using surgical robot results in incremental costs – EUR 5,562 per procedure – compared to conventional TLA. These costs are most reduced by higher number of procedures, followed by lower price of the robot, saved operation time, and reduced risk of complication, respectively. Conclusions: The incremental costs of using an autonomous surgical robot can be decreased by choosing applications with a high turnover rate, a long operation time, and a high complication rate.